Skip to main content
PolicySpeak
← All files
ESO

European Society of Oncology Pharmacy

NGO · Netherlands · EU Transparency Register 112006128054-87

2
positions filed
in the 665 files tracked
2
legislative files
of 665 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,800 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1107 non-governmental organisations on this site, they rank #614 by legislative files engaged, a count of participation, not a measure of influence.

0.2
declared lobbying FTE
self-declared
€25K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2017
in the register since

Declares membership of

  • ECO - European Cancer Organisation
  • EFGCP - European Forum for Good Clinical Practice
  • EMA Observer - European Medicines Agency

Self-declared to the EU Transparency Register (snapshot 15 Oct 2026).

Register category
Non-governmental organisations
Head office
Hamburg, Germany
EU office
Brno

Self-declared to the EU Transparency Register (snapshot 15 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track European in PolicySpeak: request access →

Follow European Society of Oncology Pharmacy

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at European Society of Oncology Pharmacy? so we know who speaks for it.

Their record over time

European Society of Oncology Pharmacy filed 2 positions between 3 Feb 2021 and 3 Nov 2023, across 2 of the 665 legislative files tracked here.

2021 · 1 filed2023 · 1 filed

What they argued

Medicinal products for human usefiled 3 Nov 2023source

ESOP Global: response to the new EU pharmaceutical legislation proposal The members of ESOP Global, who represent health care professionals from 67 countries worldwide including all countries inside the European Union, applaud the presented proposals for the new legislative pharmaceutical framework. The needs of our patients have been placed at the center of the revision.

European Health Data Spacefiled 3 Feb 2021source

The European Society of Oncology Pharmacy welcomes the start of the European Health Data Space and congratulates the European Commission for taking this ambitious step towards improving health care service delivery and outcomes for European citizens. We would like to take this opportunity to express our hope that the European Health Data Space will address the needs of our oncology patients.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put European Society of Oncology Pharmacy next to another organization. Same files, same register facts, side by side. Compare →

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.

Showing 5 of 57.

Is this your organization?

Everything on this page comes from European Society of Oncology Pharmacy’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.